{"name":"SymBio Pharmaceuticals","slug":"symbio-pharmaceuticals","ticker":"","exchange":"","domain":"symbio.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxNWDJsWUZPWkI4dlBzUGExYktCd3BDSmh0NHhRd21RdHlyZDVLWGc1bEhHOVpTY1lsckpmVkFBMzJNOTZ2by1HOU8xb0kxZ080clR4d2g1WDQ4MlIxSFJVUUg1TE1rZXp5VUdZamVWWnlUS0JyTVBkRFNoMk5XSUc3VEo0emF6Yk1qRG9N?oc=5","date":"2026-04-03","type":"pipeline","source":"MSN","summary":"CHUGAI PHARMACEUTICAL CO., LTD. (4519) - MSN","headline":"CHUGAI PHARMACEUTICAL CO., LTD. (4519)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_wFBVV95cUxNRG12S3NpMEktUmxVUjBCdlhJRFljTjNZbUhFVkZWd05OcVVvTFFNTVdUSDNzTW1BMHQ3U3VjejB1bGlSYTAzQ3k4OFZSa1Q3dHBMbDB1LXRQZHh3Tjl1YVB6LV9hakhBM1BudWRKT3NIOUYtY0t2TUJoWFl4ZHgzUkdwb0g4U2xncEtJOEQ5OExrZVNWT051YTF0QTQwU3lFSFczNS1kZDhwZjZZdnUyRHR1YTU0UVBWZHRDbVJxcDRGU3N4SUxNNGs5Yk90V3JGbEhrRzc3dENOeVlDNC1NVEJWS3hOckZZUkYtaXRPX1RwdWRiTmZib21QcVpJYWM?oc=5","date":"2026-01-13","type":"deal","source":"Citeline News & Insights","summary":"Asia Deal Watch: Eisai Obtains Rights To Nuvation’s Ibtrozi Outside US, Japan, China - Citeline News & Insights","headline":"Asia Deal Watch: Eisai Obtains Rights To Nuvation’s Ibtrozi Outside US, Japan, China - Citeline News & Insights","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiaEFVX3lxTE43YWZmalNrYmNvemxkU2tUWnVfLUpLdDZ4dG1MMTB3djVVSERoWTJiR3FiYzVDZ0gzdVdTVW9aS0w1eERyWGc5YUZVSm5EdEhMTEN1T0plYVpBc3JlVzVqeWZWa0VHLWMw?oc=5","date":"2025-09-09","type":"trial","source":"Wiley Online Library","summary":"Efficacy of ciclosporin monotherapy in non-severe aplastic anaemia not requiring transfusions: Results from a multicentre phase II study - Wiley Online Library","headline":"Efficacy of ciclosporin monotherapy in non-severe aplastic anaemia not requiring transfusions: Results from a multicentr","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAJBVV95cUxPSGhnWkIwbTRiS1BnbmdtSFhqR0QzbU4xUFQ4bnpQekdjMWdXVW1xYXVja214b2JXOGNCNV9VYVBJRDEyS0pzaGtfekxXRzZyd1M2bXpnclRMdzFYWUZvODVJSzJXcHJJUzNXRFo3ODhOQmhRc2hiMktKTDNFVjFfdUszaE8wdWFwMThDOUsxeUFyZU1XMi1Xb0dRTVFnRV9IcExRWUc5R1BZTDZjNFpObkE1TnFzdWdOQkxWcXFWSVQzLXFqNVlqMUNsUWlnUVlkOTQtU1dOUGlrN25vSXd2LUEyZDNuSGxSQVd4ZEhoRTdDM28tRmdXdzl5eHhDaG50Tzl0TWZJdW0?oc=5","date":"2025-08-27","type":"pipeline","source":"prnewswire.com","summary":"Diffuse Large B-cell Lymphoma Market to Grow at a CAGR of 13% by 2034 in Leading Markets (US, EU4, UK, and Japan) | DelveInsight - prnewswire.com","headline":"Diffuse Large B-cell Lymphoma Market to Grow at a CAGR of 13% by 2034 in Leading Markets (US, EU4, UK, and Japan) | Delv","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFBHaUwteHZ4STgxaEpMWWRKT3I2ZE1sSFRMZWJYdm1aUG1TS3VVbFBxWUZKV05xRHBxRzc0U25WLURIVVZyZFdfaHUzYlV6Ym5KMDdaWUh4NXpRQlUzOWFB?oc=5","date":"2025-02-17","type":"trial","source":"Nature","summary":"Improved prognosis of advanced-stage extranodal NK/T-cell lymphoma: results of the NKEA-Next study | Leukemia - Nature","headline":"Improved prognosis of advanced-stage extranodal NK/T-cell lymphoma: results of the NKEA-Next study | Leukemia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6wFBVV95cUxPdmVtWXVSTS1zR3BtVTJ4SVRwZlp1SUlKWHV6emJRUWtfa0IyWEtsS0lCS25VMUFMck9JMUNldXhqYjBwaE5KOWh3SEpMZHE3LWZiVlVaVWpZSEZjWHd1ajlnc1Y0eUMwTjV2YTA2Z3R4RGt0dGZYVnl1Ylp5YWJVeV9JOTB2ZWdnZjhPM1U3T09hQ1FGMFl1aUdFZmgzUDJoMng0a1FWWjRFSEFIckZIQWhTNVRvRWk3V09kdG10WnBKYm1LR1hCbTJoR2Z2eE5NMG1TLU9tZWpZWlBWXzZrZVo4ckwzS3g5MVow?oc=5","date":"2024-07-04","type":"trial","source":"prnewswire.com","summary":"BK Virus Infection Market to Witness Surge in Growth During the Study Period (2020-2034) | DelveInsight - prnewswire.com","headline":"BK Virus Infection Market to Witness Surge in Growth During the Study Period (2020-2034) | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUkFVX3lxTE1FN3NsX3JwT2dhNEljLTFkRmE2QnVjTTVhOVlSTk5IZ2pubFNYaThxRFoyQXJsckdkaWF4VjVianRmeTkwc1JRSEZJQkNYeVFWdmc?oc=5","date":"2024-04-08","type":"pipeline","source":"Yahoo Finance Australia","summary":"Traws Pharma, Inc. (TRAW) stock price, news, quote and history - Yahoo Finance Australia","headline":"Traws Pharma, Inc. (TRAW) stock price, news, quote and history","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTE9IcV9VU1Flb0xwaldNQ19zQTcwUmt4djFwNXh2WU1Jc1B3YTVlU2s1QVpEbTY5V2d1ZVBsa0I2djhKZmJJMk1HQkxwUnhMY2Q4N054QURSLWhtcXl2NkhYdjUzZWdOXzE4ZlpTaVlXd3V4eGprTExNVUxpM0tPUQ?oc=5","date":"2024-02-04","type":"pipeline","source":"ET HealthWorld","summary":"Pharma Awards - Re Pharma Awards | Health Awards from Economic Times - ET HealthWorld","headline":"Pharma Awards - Re Pharma Awards | Health Awards from Economic Times","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE9VcnltZVdYODNRZ0FQT0tZTHIyaVViUEJlc1Z4U1hKLXdoWV9lVmJSZUtDZUI4RHdWdFpCeGF2ZmR6dHpYcHRsUmpxNGxrc05yREpRdEZWY1dzbEswT1dvdDlJQjRNdmtGbUE?oc=5","date":"2023-11-23","type":"pipeline","source":"Wiley Online Library","summary":"R-CHOP treatment for patients with advanced follicular lymphoma: Over 15-year follow-up of JCOG0203 - Wiley Online Library","headline":"R-CHOP treatment for patients with advanced follicular lymphoma: Over 15-year follow-up of JCOG0203","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxQQjVhVE9sb1R5eFcyZm9JaENrbk9xR3JBbHZKdzlPNjdZdm9OVmlHSEZDa1BScUtwbmJzYWNaMVJQTjhob2VBTm5LSDhNSTUyTkdJbVRRWEJEak9PMHRyUWswLXJYUFJVR2g3Nm53bEwycl9KT2JTSVkyQUdDajQyUnI5bkM1ZlZ2cEwtdVBn?oc=5","date":"2023-11-20","type":"pipeline","source":"Contract Pharma","summary":"Symbio & Dow Group Merge with Proinnovera - Contract Pharma","headline":"Symbio & Dow Group Merge with Proinnovera","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2022-11-25","type":"pipeline","source":"medicaldialogues.in","summary":"Ex-Biocon team, Symbio Generrics completes capital raise from Ascent Capital - medicaldialogues.in","headline":"Ex-Biocon team, Symbio Generrics completes capital raise from Ascent Capital","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizwFBVV95cUxQUkpCVVRrRjdoWTVUcGVqMDNPRDM0SHh5ZmVkaVhhdFF2dU0xUjBPel96YkpqNzAtSmk4UmxkRjNjTkkwVnpBZzJlSHN6UGNWYUpRWjYwdG42S0xYYzQ5OXN0YWZFTHZINW13bjE3a1dueXBia1U3VTRzMTVYOFVqVl9aOVdwMFFHTE53QjhCc0YyV093czVsQzQ0TGNzY25mTlgwSFRXbE53S2kzMUhaMGRMdWRNUlNiNnFZSEZMX29MT2kwNmdLZXV4NmNMRGs?oc=5","date":"2022-11-24","type":"pipeline","source":"prnewswire.com","summary":"Ex-Biocon team, Symbio Generrics completes capital raise from Ascent Capital - prnewswire.com","headline":"Ex-Biocon team, Symbio Generrics completes capital raise from Ascent Capital","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}